Study of induction chemotherapy with docetaxel combined with cisplatin and fluorouracil followed by concurrent chemoradiotherapy for locally advanced nasopharyngeal carcinoma

Journal of Practical Oncology

Volumn 26, Issue 3, 2011, Pages 291-294

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; DOCETAXEL; FLUOROURACIL;

ADVANCED CANCER; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER LOCALIZATION; CANCER RADIOTHERAPY; HUMAN; NASOPHARYNX CARCINOMA;

EID: 79959553808     PISSN: 10011692     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Langendijk JA, Leemans CR, Buter J, et al. The additional value of chemotherapy to radiotherapy in locally advanced nasopheryngeal cacinoma: A meta-analysis of the published literature [J]. J Clin Oncol, 2004,22(22): 4604-4612. (Pubitemid 41185128)
2. Wolden SL, Chen WC, Pfister DG, et al. Intensity-modulated radiation therapy for nasopherynx cancer: Update of the Memorial Sloan Kettering experience [J]. Int J Radiat Oncol Biol Phys, 2006,64(1):57-62. (Pubitemid 41831209)
3. Pignor JP, Syz N, Posner M, et al. Adjusting for patient selection suggests the addition of docetaxel to 5-fluorouracil-cisplatin induction therapy may offer survival benefit in squamous cell cancer of the head and neck [J]. Anticancer Drugs, 2004,15(4):331-340. (Pubitemid 38526756)
4. Haddad R, Tishler R, Wirth L, et al. Rate of pathologic complete responses to docetaxel, cisplatin, and fluorouracil induction chemotherapy in patients with squamous cell carcinoma of the head and neck [J]. Arch Otolaryngol Head Neck Surg, 2006,132(6):314-316.
5. Hui EP, Ma BB, Leung SF, et al. Randomized phase II trial of concurrent cisplatin-radiotherapy with or without neoadjuvant docetaxel and cisplatin in advanced nasopharyngeal carcinoma [J]. J Clin Oncol, 2008,27 (2):242-249.
6. Kong L, Zhang YW, Hu CS, et al. Neoadjuvant chemotherapy followed by cocurrent chemoradiation for locally advanced nasopheryngeal cacinoma [J] Chin J Cancer, 2010,29(5):551-555.